X0708 D LIVE 0001937993 Cadrenal Therapeutics, Inc. 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 (904) 300-0701 DELAWARE None None Corporation true 2022 Quang X. Pham 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Executive Officer Director Chairman of the Board and Chief Executive Officer John P. Sharp 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Executive Officer Interim Chief Financial Officer James J. Ferguson 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Executive Officer Chief Medical Officer Jeffrey S. Cole 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Executive Officer Chief Operating Officer Lee Golden 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Director John R. Murphy 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32802 Director Glynn Wilson 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Director Biotechnology Decline to Disclose 06b false 2026-06-30 false true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue New York NY NEW YORK 10022 NY NEW YORK false 8843849 8843849 0 The total offering amount reflects the total gross proceeds to be received assuming cashexercise of all warrants issued in the private placement. false 1 315000 true 0 The placement agent received a 7.0% cash fee of $210,000, 1.0% management fee of $30,000, non-accountable expenses of $25,000, accountable expenses of $50,000 and warrants to purchase 62,4000 shares of common stock. 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Cadrenal Therapeutics, Inc. /s/ Quang X. Pham Quang X. Pham Chairman of the Board Chief Executive Officer 2026-07-15